# Corporate earnings announcements

> Live situation record from CLSTR: https://clstr.news/situations/corporate-earnings-announcements
> Updated: 2026-08-06T16:02:22.000Z. Sources: 4. Developments: 2.

In early August 2026, semiconductor firm Ceva and biopharmaceutical company Mineralys Therapeutics announced the dates for their upcoming Q2 2026 earnings releases, with analysts projecting modest earnings for Ceva and a loss for Mineralys. A few days later, biotech firms Lantheus Holdings and Cellectis reported their first‑quarter results. Lantheus posted earnings that beat expectations and modest revenue growth, while Cellectis posted a loss that narrowly beat consensus forecasts but fell short of revenue expectations. The snapshots together illustrate a brief period in which several publicly traded companies disclosed earnings schedules and then disclosed actual performance, showing a mix of positive beats and modest shortfalls across the sector.

## Timeline

### 2026-08-06: Lantheus and Cellectis Report Quarterly Earnings Beats

Lantheus posted $1.55 EPS beating $1.30 expectations; revenue $388 M. Cellectis posted a $0.22 loss beating a $0.26 loss forecast; revenue $6.9 M. Both companies saw modest stock moves.

3 sources. https://clstr.news/cluster/aldeyra-therapeutics-posts-quarterly-earnings-and-files-10q-report

### 2026-08-03: Ceva and Mineralys Therapeutics Set Q2 2026 Earnings Release Dates

Ceva will report Q2 2026 earnings on Aug 10, 2026 (expected $0.07 EPS, $28.1 B revenue); Mineralys Therapeutics will report on Aug 11, 2026 (expected loss of $0.55 EPS).

3 sources. https://clstr.news/cluster/ceva-and-village-farms-international-set-to-report-q2-2026-earnings-on-monday

---
Cite as: Corporate earnings announcements. CLSTR, https://clstr.news/situations/corporate-earnings-announcements